bf/NASDAQ:GRCL_icon.jpeg

NASDAQ:GRCL

Gracell Biotechnologies Inc.

  • Stock

USD

Last Close

10.24

21/02 21:00

Market Cap

965.02M

Beta: −1.83

Volume Today

6.37M

Avg: 131.30K

PE Ratio

−12.25

PFCF: -

Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
net income
-60.79M
-
-138.66M
128.09%
-211.90M
52.82%
-451.75M
113.19%
-607.51M
34.48%
depreciation and amortization
2.99M
-
5.12M
71.26%
21.59M
321.33%
60.27M
179.16%
77.51M
28.61%
deferred income tax
stock based compensation
60.38M
-
24.10M
60.09%
change in working capital
-4.05M
-
703K
117.34%
-10.75M
1,629.45%
25.26M
334.90%
15.08M
40.28%
accounts receivables
inventory
accounts payables
other working capital
other non cash items
-2.56M
-
2.91M
214.01%
1.30M
55.49%
8.17M
529.84%
net cash provided by operating activities
-61.86M
-
-135.39M
118.88%
-198.15M
46.35%
-304.55M
53.70%
-482.65M
58.48%
investments in property plant and equipment
-11.36M
-
-56.43M
396.89%
-79.40M
40.70%
-56.74M
28.54%
-48.39M
14.72%
acquisitions net
-97.80K
-
28.05M
28,786.09%
10M
64.36%
261.17M
2,511.66%
purchases of investments
-335M
-
-80.20M
76.06%
-28.05M
65.02%
-10M
64.36%
-261.17M
2,511.66%
sales maturities of investments
233M
-
178M
23.61%
13.51M
92.41%
25.13M
85.93%
261.22M
939.61%
other investing activites
97.80K
-
-28.05M
28,786.09%
-10M
64.36%
-261.17M
2,511.66%
net cash used for investing activites
-113.36M
-
41.37M
136.49%
-93.94M
327.09%
-41.62M
55.70%
-48.33M
16.14%
debt repayment
-10M
-
-138.82M
-
-51.29M
63.05%
-68.48M
33.50%
common stock issued
1.45B
-
common stock repurchased
-44.70M
-
dividends paid
other financing activites
148.69M
-
439.50M
195.57%
895.28M
103.70%
58.52M
93.46%
101.80M
73.96%
net cash used provided by financing activities
138.69M
-
394.80M
184.65%
756.47M
91.61%
1.46B
92.50%
33.32M
97.71%
effect of forex changes on cash
-603K
-
-22.13M
3,569.49%
-35.32M
59.63%
123.30M
449.07%
net change in cash
-36.52M
-
300.17M
921.97%
442.25M
47.33%
1.07B
143.01%
-374.36M
134.83%
cash at beginning of period
48.41M
-
11.89M
75.44%
312.06M
2,524.54%
754.31M
141.72%
1.83B
142.47%
cash at end of period
11.89M
-
312.06M
2,524.54%
754.31M
141.72%
1.83B
142.47%
1.45B
20.47%
operating cash flow
-61.86M
-
-135.39M
118.88%
-198.15M
46.35%
-304.55M
53.70%
-482.65M
58.48%
capital expenditure
-11.36M
-
-56.43M
396.89%
-79.40M
40.70%
-56.74M
28.54%
-48.39M
14.72%
free cash flow
-73.21M
-
-191.82M
162.01%
-277.55M
44.69%
-361.29M
30.17%
-531.04M
46.98%

All numbers in USD (except ratios and percentages)

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.